Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 6296-6304

  Hill, C Mark ^a   Deng, Hongkui ^a   Unutmaz, Derya ^a,b   Kewalramani, Vineet N ^a   Bastiani, Lisa ^c,d   Gorny, Miroslaw K ^c,d   Zolla Pazner, Susan ^c,d   Littman, Dan R ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MEMBRANE FUSION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ADSORPTION; VIRUS CELL INTERACTION;

EID: 1842331564     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.9.6296-6304.1997     Document Type: Article

References (94)

1. Alkhatib, G., C. Combadiere, C. C. Broder, V. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
2. Allan, J. S., J. Strauss, and D. W. Buck. 1990. Enhancement of SIV infection with soluble receptor molecules. Science 247:1084-1088.
3. Ashorn, P. A., E. A. Berger, and B. Moss. 1990. Human immunodeficiency virus envelope glycoprotein/CD4-mcdiated fusion of nonprimate cells with human cells. J. Virol. 64:2149-2156.
4. Atchison, R. E., J. Gosling, F. S. Monteclaro, C. Franci, L. Digilio, I. F. Charo, and M. A. Goldsmith. 1996. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 274: 1924-1926.
5. Banapour, B., M. L. Marthas, R. J. Munn, and P. A. Luciw. 1991. In vitro macrophage tropism of pathogenic und nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). Virology 183:12-19.
6. Banapour, B., M. L. Marthas, R. A. Ramos, B. L. Lohman, R. E. Unger, M. B. Gardner, N. C. Pedersen, and P. A. Luciw. 1991. Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac. J. Virol. 65:5798-5805.
7. Barnett, S. W., H. S. Legg, Y. Sun, J. Klinger, D. J. Blackbourn, C. P. Locher, and J. A. Levy. 1996. Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2 UC2. Virology 222:257-261.
8. Bleul, C. C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, and T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-833.
9. Brighty, D. W., M. Rosenberg, I. S. Chen, and M. Ivey-Hoyle. 1991. Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor. Proc. Natl. Acad. Sci. USA 88:7802-7805.
10. Carrillo, A., D. B. Trowbridge, P. Westervelt, and L. Ratner. 1993. Identification of HIV1 determinants for T lymphoid cell line infection. Virology 197:817-824.
11. Cheng-Mayer, C., M. Quiroga, J. W. Tung, D. Dina, and J. A. Levy. 1990. Viral determinants of human immunodeficiency virus type 1 T-cell or macrophage tropism, cytopathogenicity, and CD4 antigen modulation. J. Virol. 64:4390-4398 .
12. Chesebro, B., J. Nishio, S. Ferryman, A. Cann, W. O'Brien, I. S. Chen, and K. Wehrly. 1991. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages. J. Virol. 65:5782-5789.
13. Chesebro, B., K. Wehrly, J. Nishio, and S. Ferryman. 1992. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66:6547-6554.
14. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1133-1148.
15. Clapham, P. R., D. Blanc, and R. A. Weiss. 1991. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus. Virology 181:703-715.
16. Clapham, P. R., A. McKnight, and R. A. Weiss. 1992. Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4. J. Virol. 66:3531-3537.
17. Cocchi, F., A. L. DeVico, A. Garzino-Demo, S. K. Arya, R. C. Gallo, and P. Lusso. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270: 1811-1815.
18. Collman, R., J. W. Balliet, S. A. Gregory, H. Friedman, D. L. Kolson, N. Nathanson, and A. Srinivasan. 1992. An infectious molecular clone of an unusual macrophage-tropic and highly eytopathic strain of human immuno- deficiency virus type 1. J. Virol. 66:7517-7521.
19. Combadiere, C., S. K. Ahuja, and P. M. Murphy. 1996. Cloning and functional expression of a human eosinophil CC chemokine receptor. J. Biol. Chem. 271:11034.
20. Combadiere, C., S. K. Ahuja, H. L. Tiffany, and P. M. Murphy. 1996. Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(alpha), MIP-1(beta), and RANTES. J. Leukocyte Biol. 60:147-152.
21. Connor, R. I., B. K. Chen, S. Choe, and N. R. Landau. 1995. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206:935-944.
22. Connor, R. I., and D. D. Ho. 1994. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic age before disease progression. J. Virol. 68:4400-4408.
23. Cormack, B. P., R. H. Valdivia, and S. Falkow, 1996. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173:33-38.
24. Deen, K. C., J. S. McDougal, R. Inacker, G. Folena-Wasserman, J. Arthos, J. Rosenberg, P. J. Maddon, R. Axel, and R. W. Sweet. 1988. A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature 331:82-84.
25. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
26. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158.
27. Dragic, T., V. Litwin, G. P. Allaway, S. R. Martin, Y. Huang, K. A. Nagashima, C. Cayanan, P. J. Maddon, R. A. Koup, J. P. Moore, and W. A. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
28. a.Emerman, M. Personal communication.
29. Endres, M. J., P. R. Clapham, M. Marsh, M. Ahuja, J. D. Turner, A. McKnight, J. F. Thomas, B. Stoebenau-Haggarty, S. Choe, P. J. Vance, T. N. C. Wells, C. A. Power, S. S. Sutterwala, R. W. Doms, N. R. Landau, and J. A. Hoxie. 1996. CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87:745-756.
30. Evans, L. A., J. Moreau, K. Odehouri, H. Legg, A. Barboza, C. Cheng-Mayer, and J. A. Levy. 1988. Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression. Science 240:1522-1525.
31. Evans, L. A., J. Moreau, K. Odehouri, D. Seto, G. Thomson-Honnebier, H. Legg, A. Barboza, C. Cheng-Mayer, and J. A. Levy. 1988. Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient. Lancet 2:1389-1391.
32. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
33. Fultz, P. N., H. M. McClure, D. C. Anderson, and W. M. Switzer. 1989. Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM). AIDS Res. Hum. Retroviruses 5:397-409.
34. Gao, F., L. Yue, A. T. White, P. G. Pappas, J. Barchue, A. P. Hanson, B. M. Greene, P. M. Sharp, G. M. Shaw, and B. H. Hahn. 1992. Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature 358:495-497.
35. Gao, F., L. Yue, D. L. Robertson, S. C. Hill, H. Hui, R. J. Biggar, A. E. Neequaye, T. M. Whelan, D. D. Ho, G. M. Shaw, P. M. Sharp, and B. H. Hahn. 1994. Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J. Virol. 68:7433-7447.
36. Goldstein, S., R. Engle, R. A. Olmsted, V. M. Hirsch, and P. R. Johnson. 1990. Detection of SIV antigens by HIV-1 antigen capture immunoassays. J. Acquired Immune Defic. Syndr. 3:98-102.
37. Gorny, M. K., A. J. Conley, S. Karwowska, A. Buchbinder, J. Y. Xu, E. A. Emini, S. Koenig, and S. Zolla-Pazner. 1992. Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J. Virol. 66:7538-7542.
38. Gorny, M. K., T. C. VanCott, C. Hioe, Z. R. Israel, N. L. Michael, A. J. Conley, C. Williams, J. A. Kessler, C. Padmasree, S. Burda, and S. Zolla-Pazner. Unpublished data.
39. Gorny, M. K., J. Y. Xu, V. Gianakakos, S. Karwowska, C. Williams, H. W. Sheppard, C. V. Hanson, and S. Zolla-Pazner. 1991. Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. USA 88:3238-3242.
40. Gorny, M. K., J. Y. Xu, S. Karwowska, A. Buchbinder, and S. Zolla-Pazner. 1993. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120. J. Immunol. 150:635-643.
41. Harrowe, G., and C. Cheng-Mayer. 1995. Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. Virology 210:490-494.
42. Hirsch, V. M., G. Dapolito, R. Goeken, and B. J. Campbell. 1995. Phylogeny and natural history of the primate lentiviruses, SIV and HIV. Curr. Opin. Genet. Dev. 5:798-806. (Review.)
43. Hoxie, J. A. 1991. CD4 envelope interactions of HIV-1 and related human retroviruses. Adv. Exp. Mod. Biol. 300:159-166.
44. Hoxie, J. A. 1991. Hypothetical assignment of intrachain disulfide bonds for HIV-2 and SIV envelope glycoproteins. AIDS Res. Hum. Retroviruses 7:495-499.
45. Hoxie, J. A., B. S. Haggarty, S. E. Bonser, J. L. Rackowski, H. Shan, and P. J. Kanki.1988. Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associatcd molecules required for infection. J. Virol. 62:2557-2568.
46. Hwang, S. S., T. J. Boyle, H. K. Lyerly, and B. R. Cullen. 1992. Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science 257:535-537.
47. Ivey-Hoyle, M., J. S. Culp, M. A. Chaikin, B. D. Hellmig, T. J. Matthews, R. W. Sweet, and M. Rosenberg. 1991. Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4. Proc. Natl. Acad. Sci. USA 88:512-516.
48. Kang, C. Y., K. Hariharan, P. L. Nara, J. Sodroski, and J. P. Moore. 1994. Immunization with a soluble CD4-gpl20 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gpl20. J. Virol. 68:5854-5862.
49. 47a,Kappes, J. C., and B. H. Hahn. Personal communication.
50. Koenig, S., V. M. Hirsch, R. A. Olmsted, D. Powell, W. Maury, A. Rabson, A. S. Fauci, R. H. Purcell, and P. R. Johnson, 1989. Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion. Proc. Natl. Acad. Sci. USA 86:2443-2447.
51. Kong, L. I., S. W. Lee, J. C. Kappes, J. S. Parkin, D. Decker, J. A. Hoxie, B. H. Hahn, and G. M. Shaw. 1988. West African HIV-2-related human retrovirus with attenuated cytopathicity. Science 240:1525-1529.
52. Kumar, P., H. X. Hui, J. C. Kappes, B. S. Haggarty, J. A. Hoxle, S. K. Arya, G. M. Shaw, and B. H. Hahn. 1990. Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate. J. Virol. 64:890-901.
53. Landau, N. R., and D. R. Littman. 1992. Packaging system for rapid production of murine leukemía vírus vectors with variable tropism. J. Virol. 66:5110-5113.
54. Landau, N. R., K. A. Page, and D. R. Littman. 1991. Pseudotyping with human T-cell Ieukemia virus type I broadens the human immunodeficiency virus host range. J. Virol. 65:162-169.
55. Landau, N. R., M. Warton, and D. R. Littman. 1988. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulinlike domain of CD4. Nature 334:159-162.
56. Lapham, C. K., J. Ouyang, B. Chandrasekar, N. Y. Nguyen, D. S. Dimitrov, and H. Golding. 1996. Evidence for cell-surface association between fusin and the CD4-gpl20 complex in human cell lines. Science 274:602-605.
57. Liu, R., W. A. Paxton, S. Choe, D. Ceradini, S. R. Martin, R. Horuk, M. E. MacDonald, H. Stuhlmann, R. A. Koup, and N. R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiplyexposed individuals to HIV-1 infection. Cell 86:367-377.
58. Liu, Z. Q., C. Wood, J. A. Levy, and C. Cheng-Mayer. 1990. The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue. J. Virol. 64:6148-6153.
59. Luciw, P. A., K. E. Shaw, R. E. Unger, V. Planelles, M. W. Stout, J. E. Lackner, E. Pratt-Lowe, N. J. Leung, B. Banapour, and M. L. Marthas. 1992. Genetic and biological comparisons of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). AIDS Res. Hum. Retroviruses 8:395-402. (Review.)
60. Maddon, P. J., A. G. Dalglelsh, J. S. McDougal, P. R. Clapham, R. A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348.
61. McDougal, J. S., P. J. Maddon, A. G. Dalgleish, P. R. Clapham, D. R. Littman, M. Godfrey, D. E. Maddon, L. Chess, R. A. Weiss, and R. Axel. 1986. The T4 glycoprotein is a cell-surface receptor for the AIDS virus. Cold Spring Harbor Symp. Quant. Biol. 51(P 2):703-711.
62. McKnight, A., P. R. Clapham, and R. A. Weiss. 1994. HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: restrictions to replication at distinct stages. Virology 201:8-18.
63. Meyer, A., A. J. Coyle, A. E. Proudfoot, T. N. Wells, and C. A. Power. 1996. Cloning and characterization of a novel murine macrophage inflammatory protein-1 alpha receptor. J. Biol. Chem. 271:14445-14451.
64. Moore, J. P., A. Trkola, B. Korber, L. J. Boots, J. A. N. Kessler, F. E. McCutchan, J. Mascola, D. D. Ho, J. Robinson, and A. J. Conley. 1995. A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B. J. Virol. 69:122-130.
65. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multíple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
66. Mori, K., D. J. Ringler, and R. C. Desrosiers. 1993. Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry. J. Virol. 67:2807-2814.
67. Mori, K., D. J. Ringler, T. Kodama, and R. C. Desrosiers. 1992. Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J. Virol. 66:2067-2075.
68. Murphy, P. M. 1995. Blood, sweat, and chemotactic cytokines. J. Leukocyte Biol. 57:438-439.
69. Murphy, P. M. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593-633. (Review.)
70. mac. J. Virol. 62:4691-4696.
71. Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J.-L. Virelizier, F. ArenzanaSeisdedos, O. Schwartz, J.-M. Heard, I. Clark-Lewis, D. F. Legler, M. Loetscher, M. Bagglioni, and B. Moser. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382:833-835.
72. O'Brien, W. A., Y. Koyanagl, A. Namazie, J. Q. Zhao, A. Diagne, K. Idler, J. A. Zack, and I. S. Chen. 1990. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 348:69-73.
73. Ohta, Y., T. Masuda, H. Tsujimoto, K. Ishikawa, T. Kodama, S. Morikawa, M. Nakai, S. Honjo, and M. Hayami. 1988. Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates. Int. J. Cancer 41:115-122.
74. Onishi, M., S. Kinoshita, Y. Morikawa, A. Shibuya, J. Phillips, L. L. Lanier, D. M. Gorman, G. P. Nolan, A. Miyajima, and T. Kitamura. 1996. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 24:324-329.
75. Page, K, A., N. R. Landau, and D. R. Littman. 1990. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64:5270-5277.
76. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
77. Rucker, J., M. Samson, B. J. Doranz, F. Libert, J. F. Berson, Y. Yi, R. J. Smyth, R. G. Collman, C. C. Broder, G. Vassart, R. W. Doms, and M. Parmentíer. 1996. Regions in b-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell 87:437-448.
78. Samson, M., O. Labbe, C. Mollereau, G. Vassart, and M. Parmentier. 1996. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35:3362-3367.
79. Sattentau, Q. J., P. R. Clapham, R. A. Weiss, P. C. Beverley, L. Montagnier, M. F. Alhalabi, J. C. Gluckmann, and D. Klatzmann. 1988. The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. AIDS 2:101-105.
80. Sattentau, Q. J., A. G. Dalgleish, R. A. Weiss, and P. C. Beverley. 1986. Epitopes of the CD4 antigen and HIV infection. Science 234:1120-1123.
81. Sattentau, Q. J., and R. A. Weiss. 1988. The CD4 antigen: physiological ligand and HIV receptor. Cell 52:631-633. (Review.)
82. Schall, T. J., and K. B. Bacon. 1994. Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6:865-873. (Review.)
83. Shioda, T., J. A. Levy, and C. Cheng-Mayer. 1992. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 89:9434-9438.
84. Stamatatos, L., S. Zolla-Pazner, M. K. Gorny, and C. Cheng-Mayer. Binding of antibodies to virion-associated gp120 molecules of primary-like HIV-1 ísolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells. Virology, in press.
85. Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. Sodroskí. 1995. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
86. Trkola, A., T. Dragic, J. Artnos, J. M. Binley, W. C. Olson, G. P. Allaway, C. Cheng-Mayer, J. Robinson, P. J. Maddon, and J. P. Moore. 1996. CD4dependent, antibody-sensitive interactions between HIV-1 and its coreceptor CCR-5. Nature 384:184-187.
87. Unger, R. E., M. L. Marthas, E. Pratt-Lowe, P. A. Padrid, and P. A. Luciw. 1992. The nef gene of simian immunodeficiency virus SIVmaclA11. J. Virol. 66:5432-5442.
88. Weiss, R. A., P. R. Clapham, M. O. McClure, J. A. McKeating, A. McKnight, A. G. Dalgleísh, Q. J. Sattentau, and J. N. Weber. 1988. Human immunodeficiency viruses: neutralization and receptors. J. Acquired Immune Defic. Syndr. 1:536-541. (Review.)
89. Werner, A., G, Winskowsky, and R. Kurth. 1990. Soluble CD4 enhances simian immunodeficiency virus SIVagm infection. J. Virol. 64:6252-6256.
90. Westervelt, P., H. E. Gendelman, and L. Ratner. 1991. Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc. Natl. Acad. Sci. USA 88:3097-3101.
91. Westervelt, P., D. B. Trowbridge, L. G. Epstein, B. M. Blumberg, Y. Li, B. H. Hahn, G. M. Shaw, R. W. Price, and L. Ratner. 1992. Macrophage iropism determinants of human immunodeficiency virus type 1 in vivo. J. Virol. 66:2577-2582.
92. Wu, L., N. P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Bursetti, A. A. Cardoso, E. Desjardin, W. Newman, C. Gerard, and J. Sodroski. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179-183.
93. Zingler, K., and D. R. Littman. 1993. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases Env incorporation into particles and fusogenicity and infectivity. J. Virol. 67: 2824-2831.
94. Zolla-Pazner, S., J. O'Leary, S. Burda, M. K. Gorny, M. Kim, J. Mascola, and F. McCutchan. 1995. Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. J. Virol. 69:3807-3815.